Stephen Ferber, MD
Psychiatry
Highlights
Age Groups Seen
- Adult
Languages
- English
Gender
MaleAbout Stephen Ferber
Title
Assistant Director - The Psychiatric Treatment-Resistance Program at Cleveland Clinic
Biography
Dr. Stephen Ferber currently serves as the Assistant Director of The Psychiatric Treatment-Resistance Program at Cleveland Clinic. He has extensive experience in the management of treatment-resistant mental health conditions, specializing in interventional psychiatry with a focus on Transcranial Magnetic Stimulation (TMS), Ketamine, and Electroconvulsive Therapy (ECT). Dr. Ferber’s research has focused on targeting strategies in TMS, and he maintains active membership in the International Society for ECT and Neurostimulation as well as the Clinical TMS Society. He has also devoted significant time to medical student and residency education, developing numerous didactics and electives focusing on circuit-based care and the utilization of the primary interventional modalities.
Education & Board Certifications
Education
- Fellowship: Massachusetts General Hospital, 2021
- Residency: Columbia University Medical Center-New York Presbyterian Hospital, 2019
- Medical Education: Herbert Wertheim College of Medicine, 2015
- Undergraduate: Carleton College, 2011
Board Certifications
- Psychiatry: American Board of Psychiatry & Neurology, 2019
Professional Memberships
Innovations & Patents
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2025-10-02, Dr. Ferber has reported no financial relationship with industry that is applicable to this listing.
In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.